Endothelial protein C receptor polymorphisms and risk of myocardial infarction
暂无分享,去创建一个
Javier Corral | Esther Zorio | R. Bertina | F. España | A. Estellés | F. Marín | J. Corral | A. Santamaría | Francisco España | E. Zorio | Francisco Marín | J. Rueda | Rogier M Bertina | P. Medina | Joaquín Rueda | V. Roldán | Amparo Estellés | Pilar Medina | Silvia Navarro | Vanessa Roldán | Amparo Santamaría | S. Navarro
[1] M. Margaglione,et al. No Evidence of Association Between Prothrombotic Gene Polymorphisms and the Development of Acute Myocardial Infarction at a Young Age , 2003, Circulation.
[2] María Dolores Ruiz López,et al. Factores de riesgo cardiovascular en la región de Murcia, España , 1997 .
[3] F R Rosendaal,et al. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis , 2004, Journal of thrombosis and haemostasis : JTH.
[4] J. Weiss,et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. , 1996, The New England journal of medicine.
[5] P. Mannucci,et al. Autoantibodies against the endothelial receptor of protein C are associated with acute myocardial infarction in young women , 2005, Journal of thrombosis and haemostasis : JTH.
[6] José A Fernández,et al. Activated protein C and inflammation in human myocardium after heart surgery , 2001, American journal of hematology.
[7] I. Édes,et al. Elevated factor XIII level and the risk of myocardial infarction in women. , 2007, Haematologica.
[8] W. Ruf,et al. Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.
[9] F. España,et al. The multifunctional protein C system. , 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents.
[10] F. Rosendaal,et al. Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis , 2007, Journal of thrombosis and haemostasis : JTH.
[11] K. Fukudome,et al. Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity , 2007, Journal of thrombosis and haemostasis : JTH.
[12] J. Griffin,et al. The cytoprotective protein C pathway. , 2007, Blood.
[13] Justo Aznar,et al. Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk , 2004, Thrombosis and Haemostasis.
[14] J S Yudkin,et al. EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. , 2005, Atherosclerosis.
[15] P. Grant,et al. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. , 2000, Blood.
[16] C. Esmon,et al. The Ser219–>Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype , 2006, Journal of thrombosis and haemostasis : JTH.
[17] B. Grinnell,et al. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-&kgr;B , 2002, Critical care medicine.
[18] F. España,et al. Quantification of Circulating Activated Protein C in Human Plasma by Immunoassays - Enzyme Levels are Proportional to Total Protein C Levels , 1996, Thrombosis and Haemostasis.
[19] F. España,et al. Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions 1 , 2006, Journal of thrombosis and haemostasis : JTH.
[20] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[21] R. Bertina,et al. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden , 2005, Thrombosis and Haemostasis.
[22] C. Esmon,et al. Reconstitution of the Human Endothelial Cell Protein C Receptor with Thrombomodulin in Phosphatidylcholine Vesicles Enhances Protein C Activation* , 1999, The Journal of Biological Chemistry.
[23] C. Esmon,et al. Endothelial Cell Protein C Receptor Acts as a Cellular Receptor for Factor VIIa on Endothelium* , 2007, Journal of Biological Chemistry.
[24] L. Fisher,et al. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). , 1995, Journal of the American College of Cardiology.
[25] R. Bertina,et al. Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation , 2008, Haematologica.
[26] C. Esmon,et al. Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor‐α converting enzyme/ADAM17 , 2007, Journal of thrombosis and haemostasis : JTH.
[27] M. Williams,et al. Myocardial infarction in young people with normal coronary arteries , 1998, Heart.
[28] J. Reny,et al. A HAPLOTYPE OF THE EPCR GENE IS ASSOCIATED WITH INCREASED PLASMA LEVELS OF sEPCR AND IS A CANDIDATE RISK FACTOR FOR THROMBOSIS Short title : EPCR gene , sEPCR level and thrombotic , 2003 .
[29] C. Esmon,et al. Regulation and functions of the protein C anticoagulant pathway. , 1999, Haematologica.
[30] C. Esmon,et al. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin , 2005, Journal of thrombosis and haemostasis : JTH.
[31] F. Marín,et al. Prognostic value of annexin A5 −1 C/T polymorphism in a long term follow‐up after premature myocardial infarction , 2007, Journal of thrombosis and haemostasis : JTH.
[32] W. Bode,et al. Inflammation, sepsis, and coagulation. , 1999, Haematologica.
[33] C. Esmon,et al. Identification of functional endothelial protein C receptor in human plasma. , 1997, The Journal of clinical investigation.